Literature DB >> 11386421

Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing.

P Utaisincharoen1, N Tangthawornchaikul, W Kespichayawattana, P Chaisuriya, S Sirisinha.   

Abstract

Burkholderia pseudomallei is a causative agent of melioidosis, a life threatening disease which affects humans and animals in tropical and subtropical areas. This bacterium is known to survive and multiply inside cells such as macrophages. The mechanism of host defense against this bacterium is still unknown. In this study, we demonstrated that B. pseudomallei exhibited unique macrophage activation activity compared with Escherichia coli and Salmonella typhi. The mouse macrophage cell line (RAW 264.7) infected with B. pseudomallei at MOI of 0.1:1, 1:1 and 10:1 did not express a detectable level of inducible nitric oxide synthase (iNOS). Moreover, the B. pseudomallei infected cells released TNF-alpha only when they were infected with high MOI (10:1). Unlike the cells infected with B. pseudomallei, the cells infected with E. coli, and S. typhi expressed iNOS even at MOI of 0.1:1. These infected cells also released a significantly higher level of TNF-alpha at the low MOI ratio. The cells that were preactivated with IFN-gamma prior to being infected with B. pseudomallei exhibited an enhanced production of iNOS and TNF-alpha release. The increased macrophage activation activity in the presence of IFN-gamma also correlated with the restriction of the intracellular bacteria survival. Moreover, IFN-gamma also prevented cell fusion and multinucleated cell formation induced by B. pseudomallei, a phenomenon recently described by our group. Altogether, these results indicate that internalization of B. pseudomallei failed to trigger substantial macrophage activation, a phenomenon which could prolong their survival inside the phagocytic cells and facilitate a direct cell to cell spreading of B. pseudomallei to neighboring cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386421     DOI: 10.1111/j.1348-0421.2001.tb02623.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  43 in total

1.  Horizontal gene transfer of "prototype" Nramp in bacteria.

Authors:  Etienne Richer; Pascal Courville; Isabelle Bergevin; Mathieu F M Cellier
Journal:  J Mol Evol       Date:  2003-10       Impact factor: 2.395

2.  Role of the stationary growth phase sigma factor RpoS of Burkholderia pseudomallei in response to physiological stress conditions.

Authors:  Benchamas Subsin; Mark S Thomas; Gerd Katzenmeier; Jonathan G Shaw; Sumalee Tungpradabkul; Mongkol Kunakorn
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

3.  Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.

Authors:  Katie L Propst; Ryan M Troyer; Lisa M Kellihan; Herbert P Schweizer; Steven W Dow
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

4.  Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival.

Authors:  S Arjcharoen; C Wikraiphat; M Pudla; K Limposuwan; D E Woods; S Sirisinha; P Utaisincharoen
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

5.  Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; Paul J Brett; Vinod Nair; Jonathan M Warawa; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

6.  Burkholderia pseudomallei-induced expression of a negative regulator, sterile-alpha and Armadillo motif-containing protein, in mouse macrophages: a possible mechanism for suppression of the MyD88-independent pathway.

Authors:  M Pudla; K Limposuwan; P Utaisincharoen
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

Review 7.  Autophagy and burkholderia.

Authors:  Rodney J Devenish; Shu-chin Lai
Journal:  Immunol Cell Biol       Date:  2014-10-21       Impact factor: 5.126

8.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

9.  Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  P Utaisincharoen; N Anuntagool; S Arjcharoen; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  Ubiquity of putative type III secretion genes among clinical and environmental Burkholderia pseudomallei isolates in Northern Australia.

Authors:  H C Smith-Vaughan; D Gal; P M Lawrie; C Winstanley; K S Sriprakash; B J Currie
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.